Most Recent Links
Follow us on Facebook or subscribe to our mailing list, to receive news updates. Learn more.
Jon Hamilton A key protein that helps assemble the brain early in life also appears to protect the organ from Alzheimer’s and other diseases of aging. A trio of studies published in the past year all suggest that the protein Reelin helps maintain thinking and memory in ailing brains, though precisely how it does this remains uncertain. The studies also show that when Reelin levels fall, neurons become more vulnerable. There’s growing evidence that Reelin acts as a “protective factor” in the brain, says Li-Huei Tsai, a professor at MIT and director of the Picower Institute for Learning and Memory. “I think we’re on to something important for Alzheimer’s,” Tsai says. Various pieces of colorful trash, such as plastic bottle caps and plastics forks, are arranged in the shape of a human brain, on a light blue background. The research has inspired efforts to develop a drug that boosts Reelin or helps it function better, as a way to stave off cognitive decline. “You don't have to be a genius to be like, ‘More Reelin, that’s the solution,’” says Dr. Joseph Arboleda-Velasquez of Harvard Medical School and Massachusetts Eye and Ear. “And now we have the tools to do that.” From Colombia, a very special brain Reelin became something of a scientific celebrity in 2023, thanks to a study of a Colombian man who should have developed Alzheimer’s in middle age but didn’t. The man, who worked as a mechanic, was part of a large family that carries a very rare gene variant known as Paisa, a reference to the area around Medellin where it was discovered. Family members who inherit this variant are all but certain to develop Alzheimer’s in middle age. © 2024 npr
Keyword: Alzheimers; Development of the Brain
Link ID: 29413 - Posted: 07.31.2024
By Katie Moisse Monkeys can memorize a sequence of images and then toggle between them in their minds, a new study has found. Each mental move is associated with a tiny burst of brain activity that could be the neural representation of a thought, the study authors say. The study is the first to find evidence that an animal creates cognitive maps based on experience and later uses them exclusively, without any sensory input, to navigate a new task. It also marks one of the first times researchers have registered brain activity tied to an ongoing, complex thought process. “It’s a very fluid process—the process of thinking. And we have no way in animals to know what they’re thinking and therefore map what we record in the brain to what’s happening in the mind,” says study investigator Mehrdad Jazayeri, professor and director of education, brain and cognitive sciences at MIT’s McGovern Institute and a Howard Hughes Medical Institute investigator. In the new study, however, Jazayeri and his team designed a task that requires the animal to imagine a specific scenario at a specific time. “Imagination: There’s no magic to it; it’s a pattern of activity in the brain,” he says. Previous studies suggest rodents use cognitive maps to recreate the past and predict future possibilities. The new study, published last month in Nature, suggests monkeys also engage in such mental simulation and do so in the present—imagining states of the world that they just can’t see. “It’s a little bit like an animal navigating in the dark, where they’re using an internal map of where they are and where they’re going to update their sense of how close they are to their goal,” says Loren Frank, professor of physiology at the University of California, San Francisco, School of Medicine and a Howard Hughes Medical Institute investigator, who was not involved in the work. “Our brains do this all the time. But this study gives us a sense of how they do it and shows there’s an identifiable underlying process. It’s a really nice step forward.” Research image of the activity of a single neuron in a monkey brain. © 2024 Simons Foundation
Keyword: Learning & Memory; Evolution
Link ID: 29412 - Posted: 07.31.2024
By Hannah Richter Humans aren’t the only animals that lose hearing as they grow older. Almost every mammal studied struggles to pick up some sounds as they age. Some veterinarians even fit dogs for tiny hearing aids. But at least one species of bat appears to be an exception. Reporting this month on the preprint server bioRxiv, scientists have discovered that big brown bats (Eptesicus fuscus) don’t hear any worse as they grow older, possibly because their ability to echolocate is so critical to their survival. “Hearing is kind of their superpower,” says Mirjam Knörnschild, a behavioral ecologist at the Museum of Natural History Berlin who was not involved with the work. The research, she and others say, could lead to new ways to understand—and possibly treat—hearing loss in humans. Bats actually have two superpowers. Not only can most of them echolocate—bouncing sound off objects to hunt and navigate—they also tend to be remarkably long-lived for their size. Most small mammals are short-lived, but compared with mice of similar stature, the big brown bat lives up to five times as long, sometimes topping out at 19 years old. That makes the species a fascinating target for studies of aging, says Grace Capshaw, a postdoctoral researcher at Johns Hopkins University. The bat auditory system is fundamentally the same as that of every other mammal, she says, so “bats can be a really powerful model for comparing how hearing works.” To test whether big brown bats lose their hearing over time, Capshaw and colleagues divided 23 wild-caught bats into groups of young and old, making 6 years—the mean age of the species—the dividing line. The researchers determined the bats’ ages using a precise genetic method that involves comparing each animal’s DNA with the DNA of bats with known ages. They then sedated the animals to conduct a hearing examination similar to those done on human infants.
Keyword: Hearing
Link ID: 29411 - Posted: 07.31.2024
By Pam Belluck Scientists have made another major stride toward the long-sought goal of diagnosing Alzheimer’s disease with a simple blood test. On Sunday, a team of researchers reported that a blood test was significantly more accurate than doctors’ interpretation of cognitive tests and CT scans in signaling the condition. The study, published Sunday in the journal JAMA, found that about 90 percent of the time the blood test correctly identified whether patients with memory problems had Alzheimer’s. Dementia specialists using standard methods that did not include expensive PET scans or invasive spinal taps were accurate 73 percent of the time, while primary care doctors using those methods got it right only 61 percent of the time. “Not too long ago measuring pathology in the brain of a living human was considered just impossible,” said Dr. Jason Karlawish, a co-director of the Penn Memory Center at the University of Pennsylvania who was not involved in the research. “This study adds to the revolution that has occurred in our ability to measure what’s going on in the brain of living humans.” The results, presented Sunday at the Alzheimer’s Association International Conference in Philadelphia, are the latest milestone in the search for affordable and accessible ways to diagnose Alzheimer’s, a disease that afflicts nearly seven million Americans and over 32 million people worldwide. Medical experts say the findings bring the field closer to a day when people might receive routine blood tests for cognitive impairment as part of primary care checkups, similar to the way they receive cholesterol tests. “Now, we screen people with mammograms and PSA or prostate exams and other things to look for very early signs of cancer,” said Dr. Adam Boxer, a neurologist at the University of California, San Francisco, who was not involved in the study. “And I think we’re going to be doing the same thing for Alzheimer’s disease and hopefully other forms of neurodegeneration.” © 2024 The New York Times Company
Keyword: Alzheimers
Link ID: 29410 - Posted: 07.31.2024
By Miryam Naddaf Researchers have identified neurons in the brains of baby mice that enable them to form a unique, strong bond with their mother in the first few days of life. Stimulating these neurons in mouse pups that had been separated from their mother could mimic the soothing effect of their mother’s presence, and reduced behaviours associated with stress. The findings, published today in Science1, offer fresh clues about the formation of the mother–infant bond in mammals, and could help researchers to better understand how brain development influences behaviour. “We know very little about how the brains of infants make sense of their social world,” says study co-author Marcelo Dietrich, a neurobiologist at Yale University in New Haven, Connecticut. “When I started my lab ten years ago, and I wanted to study this kind of stuff, people said it was delusional. It will fail. It’s too difficult.” Now, “we show that it’s possible: one can do rigorous science and try to understand these mechanisms that are potentially very important for development and health”. “I see these neurons as the ‘I feel good with mommy’ neurons,” says Catharine Dulac, a neuroscientist at the University of Harvard in Cambridge, Massachusetts. “The features that [they] discovered provide some framework to think about humans.” Bonding in the brain Dietrich and his team studied nursing mouse pups that were between 16 and 18 days old. They used live imaging techniques to record activity in the zona incerta (ZI), a thin layer of grey matter located below the thalamus, while the animals interacted with their mother. © 2024 Springer Nature Limited
Keyword: Sexual Behavior
Link ID: 29409 - Posted: 07.27.2024
By Carl Zimmer After analyzing decades-old videos of captive chimpanzees, scientists have concluded that the animals could utter a human word: “mama.” It’s not exactly the expansive dialogue in this year’s “Kingdom of the Planet of the Apes.” But the finding, published on Thursday in the journal Scientific Reports, may offer some important clues as to how speech evolved. The researchers argue that our common ancestors with chimpanzees had brains already equipped with some of the building blocks needed for talking. Adriano Lameira, an evolutionary psychologist at the University of Warwick in Britain and one of the authors of the study, said that the ability to speak is perhaps the most important feature that sets us apart from other animals. Talking to each other allowed early humans to cooperate and amass knowledge over generations. “It is the only trait that explains why we’ve been able to change the face of the earth,” Dr. Lameira said. “We would be an unremarkable ape without it.” Scientists have long wondered why we can speak and other apes cannot. Beginning in the early 1900s, that curiosity led to a series of odd — and cruel — experiments. A few researchers tried raising apes in their own homes to see if living with humans could lead the young animals to speak. In 1947, for example, the psychologist Keith Hayes and his wife, Catherine, adopted an infant chimpanzee. They named her Viki, and, when she was five months old, they started teaching her words. After two years of training, the couple later claimed, Viki could say “papa,” “mama,” “up” and “cup.” By the 1980s, many scientists had dismissed the experiences of Viki and other adopted apes. For one, separating babies from their mothers was likely traumatic. “It’s not the sort of thing you could fund anymore, and with good reason,” said Axel Ekstrom, a speech scientist at the KTH Royal Institute of Technology in Stockholm. © 2024 The New York Times Company
Keyword: Language; Evolution
Link ID: 29408 - Posted: 07.27.2024
By Laura Dattaro When John Tuthill was a postdoctoral researcher at Harvard Medical School, he worked just down the hall from Wei-Chung Allen Lee, who was developing new technology to image and map cell connections in the central nervous system. Lee wanted to use his technique in the fruit fly Drosophila, but he knew that other groups were already making such images of the fly brain. So Tuthill, who was studying touch stimuli in Drosophila, suggested Lee pivot to map the fly’s ventral nerve cord (VNC) instead. A decade later, Tuthill, Lee and colleagues have published a map of the connections among motor neurons in a female fly’s VNC, which is analogous to the spinal cord in mammals. The diagram, published on 26 June in Nature, details roughly 45 million synapses that connect nearly 15,000 neurons, and is the second such connectome to be released. A different team, at Howard Hughes Medical Institute’s Janelia Research Campus, published a male fly’s VNC connectome to eLife’s preprint server in June 2023. (The team posted an updated, reviewed preprint on 23 May 2024.) “The connectome is only useful if you can connect it to the muscles,” says Tuthill, associate professor of neuroscience at the University of Washington. “The output of the connectome is the activity of motor neurons.” With connectomes from both a male and a female fly, researchers are starting to look for differences not only between individuals, but between the sexes. An initial comparison of the two connectomes, posted to bioRxiv on 28 June by members of both teams, including Tuthill and Lee, identified circuits that appear to control sex-specific behaviors, including male courtship songs and the female extension of an organ used to deposit eggs. © 2024 Simons Foundation
Keyword: Brain imaging
Link ID: 29407 - Posted: 07.27.2024
By Vivian La Great Basin was burning the midnight oil on a chilly fall evening in 2016 when he made his move. Slinking out of the shadows in Laramie, Wyoming, the raccoon approached what looked like a metal filing cabinet lying on its side. He could smell a mix of dog kibble and sardines within, but 12 latched narrow doors blocked his entry. Making matters worse, a fellow raccoon had beaten him there. So Great Basin jumped on top of the cabinet and began to fiddle with the latches upside down. He quickly opened one of the doors, securing the treats and filling his belly. Humans have long regarded raccoons—renowned for their ability to jimmy their way into locked garbage cans and enter seemingly impassable attics—with a mixture of awe and scorn. But outside of the lab, researchers have little scientific sense of how clever these “trash pandas” really are. A study published today in the Proceedings of the Royal Society B: Biological Sciences may change that. The work was led by Lauren Stanton, a cognitive ecologist at the University of California, Berkeley who has studied raccoons for 10 years. She says she’s drawn by their quirky personalities and quick ability to adapt to environments such as urban areas. “I think it’s fascinating to think about how raccoons perceive the world.” Despite their reputation for cleverness, Stanton says raccoons generally are understudied because they can be “a menace in the lab,” gnawing on cages and biting scientists. Research on wild raccoons is even more scarce. © 2024 American Association for the Advancement of Science.
Keyword: Learning & Memory; Evolution
Link ID: 29406 - Posted: 07.27.2024
By Bianca Nogrady The ability to remember and recognize a musical theme does not seem to be affected by age, unlike many other forms of memory. “You’ll hear anecdotes all the time of how people with severe Alzheimer’s can’t speak, can’t recognize people, but will sing the songs of their childhood or play the piano,” says Sarah Sauvé, a feminist music scientist now at the University of Lincoln in the United Kingdom. Past research has shown that many aspects of memory are affected by ageing, such as recall tasks that require real-time processing, whereas recognition tasks that rely on well-known information and automatic processes are not. The effect of age on the ability to recall music has also been investigated, but Sauvé was interested in exploring this effect in a real-world setting such as a concert. In her study1, published today in PLoS ONE, she tested how well a group of roughly 90 healthy adults, ranging in age from 18 to 86 years, were able to recognize familiar and unfamiliar musical themes at a live concert. Participants were recruited at a performance of the Newfoundland Symphony Orchestra in St John’s, Canada. Another 31 people watched a recording of the concert in a laboratory. The study focused on three pieces of music played at the concert: Eine kleine Nachtmusik by Mozart, which the researchers assumed most participants were familiar with, and two specially commissioned experimental pieces. One of these was tonal and easy to listen to; the other was more atonal and didn’t conform to the typical melodic norms of Western classical music. A short melodic phrase from each of the three pieces was played three times at the beginning of that piece, and participants then logged whenever they recognized that theme in the piece. © 2024 Springer Nature Limited
Keyword: Learning & Memory; Alzheimers
Link ID: 29405 - Posted: 07.27.2024
By Christina Caron The 6-year-old boy sitting across from Douglas Tynan, a child and adolescent clinical psychologist based in Delaware, clearly did not have attention deficit hyperactivity disorder. Dr. Tynan was sure of that. But the boy’s first-grade teacher disagreed. He could be inattentive in class, but at home his behavior wasn’t out of the ordinary for a child his age. A voracious reader, he told Dr. Tynan that he liked to bring his own books to school because the ones in class were too easy. What his teacher had not considered was that the child was most likely academically gifted, as his mother had been as a child, Dr. Tynan said. (Studies have shown that Black children, like the boy in his office, are less likely to be identified for gifted programs.) Further testing revealed that Dr. Tynan was correct. The child wasn’t inattentive in school because of A.D.H.D. It was because he was bored. A.D.H.D. is a neurodevelopmental disorder that begins in childhood and typically involves inattention, disorganization, hyperactivity and impulsivity that cause trouble in two or more settings, like at home and at school. But those symptoms — for children and adults alike — can overlap with a multitude of other traits and disorders. In fact, difficulty concentrating is one of the most common symptoms listed in the American Psychiatric Association’s diagnostic manual, and it’s associated with 17 diagnoses, according to a study published in April. Patients need a careful evaluation to avoid either being misdiagnosed with A.D.H.D. or having a missed A.D.H.D. diagnosis. Here’s a look at some common problems that can mimic A.D.H.D. Mental health conditions like anxiety, depression or oppositional defiant disorder can show up as A.D.H.D.-like symptoms. © 2024 The New York Times Company
Keyword: ADHD; Development of the Brain
Link ID: 29404 - Posted: 07.27.2024
By Cathleen O’Grady Human conversations are rapid-fire affairs, with mere milliseconds passing between one person’s utterance and their partner’s response. This speedy turn taking is universal across cultures—but now it turns out that chimpanzees do it, too. By analyzing thousands of gestures from chimpanzees in five different communities in East Africa, researchers found that the animals take turns while communicating, and do so as quickly as we do. The speedy gestural conversations are also seen across chimp communities, just like in humans, the authors report today in Current Biology. The finding is “very exciting” says Maël Leroux, an evolutionary biologist at the University of Rennes who was not involved with the work. “Language is the hallmark of our species … and a central feature of language is our ability to take turns.” Finding a similar behavior in our closest living relative, he says, suggests we may have inherited this ability from our shared common ancestor. When chimps gesture—such as reaching out an arm in a begging gesture—they are most often making a request, says Gal Badihi, an animal communication researcher at the University of St Andrews. This can include things such as “groom me,” “give me,” or “travel with me.” Most of the time, the chimp’s partner does the requested behavior. But sometimes, the second chimp will respond with its own gestures instead—for instance, one chimp requesting grooming, and the other indicating where they would like to be groomed, essentially saying “groom me first.” To figure out whether these interactions resemble human turn taking, Badihi and colleagues combed through hundreds of hours of footage from a massive database of chimpanzee gestural interactions recorded by multiple researchers across decades of fieldwork in East Africa. The scientists studied the footage, describing the precise movements each chimp made when gesturing, the response of other chimps, the duration of the gestures, and other details. © 2024 American Association for the Advancement of Science.
Keyword: Language; Evolution
Link ID: 29403 - Posted: 07.23.2024
By Gina Kolata People with obesity now have a choice between two powerful drugs to help them lose weight. One is semaglutide, sold by Novo Nordisk as Wegovy for obesity treatment and as Ozempic for diabetes. The second, tirzepatide, is sold by Eli Lilly as Zepbound for obesity and as Mounjaro for diabetes. Many with neither obesity or diabetes take the drugs to get thinner. A recent study suggested that people lost more weight taking Mounjaro than they did taking Ozempic, and it may leave you wondering: Which should I take? And if I’m already taking one of them, should I switch? The answers, obesity medicine experts say, are not so simple. Here are some factors that can help sort out hype from realistic hope. Is one weight loss drug really better than the other? For now, it’s hard to say. All of the information available comes from “highly flawed studies,” said Dr. Diana Thiara, medical director of the weight loss clinic at the University of California, San Francisco. That includes the recent study comparing Mounjaro and Ozempic. Using electronic health records, the researchers reported that those taking Mounjaro lost an average of 15.3 percent of their weight after a year. Those taking Ozempic lost an average of 8.3 percent. While that sounds impressive, Dr. Susan Z. Yanovski, co-director of the Office of Obesity Research at the National Institute of Diabetes and Digestive and Kidney Diseases, said, “I wouldn’t make any decisions on my medical care based solely on a study like this.” There’s an inherent difficulty in using electronic health records, she noted, because it is not known why the patients were taking the drugs — the study was underway before Zepbound was approved for treating obesity. The investigators looked at prescriptions for Ozempic and Mounjaro, which were approved to treat diabetes. Yet many in the study did not have diabetes. © 2024 The New York Times Company
Keyword: Obesity
Link ID: 29402 - Posted: 07.23.2024
Oscar Allan The sluggish start to the day, the struggle to concentrate on everyday tasks and the lethargy that comes with just a few hours sleep, these are the symptoms that will be familiar to anyone who suffers with insomnia. But according to research, not all sleepless nights are the same. Brain scans have revealed evidence for distinct forms of insomnia, each with an associated pattern of neural wiring. And while the clinical distinction may mean little to those whose days are blighted by sleep deprivation, the discovery does raise the prospect of tailored interventions for people with different kinds of insomnia, which could lead to better treatments. Researchers at the Netherlands Institute for Neuroscience in Amsterdam analysed MRI scans from more than 200 insomniacs and dozens of sound sleepers and spotted structural changes that distinguished sleepers from the sleepless and five separate forms of insomnia. “If these subtypes differ in their biological mechanism, then patients in each subtype might benefit from different focused treatments,” said Tom Bresser, a neuroscientist and first author on the study. Insomnia is broadly defined as poor sleep, generally due to difficulties falling or staying asleep, which negatively affects daytime functioning. About a third of adults in western countries have sleep problems at least once a week, with up to 10% qualifying for a formal insomnia diagnosis. Chronic insomnia is diagnosed if someone suffers sleep problems on at least three nights a week for three months or more. The condition is nearly twice as common in women than men. © 2024 Guardian News & Media Limited
Keyword: Sleep
Link ID: 29401 - Posted: 07.23.2024
By Dana G. Smith Getting too little sleep later in life is associated with an increased risk for Alzheimer’s disease. But paradoxically, so is getting too much sleep. While scientists are confident that a connection between sleep and dementia exists, the nature of that connection is complicated. It could be that poor sleep triggers changes in the brain that cause dementia. Or people’s sleep might be disrupted because of an underlying health issue that also affects brain health. And changes in sleep patterns can be an early sign of dementia itself. Here’s how experts think about these various connections and how to gauge your risk based on your own sleep habits. Too Little Sleep Sleep acts like a nightly shower for the brain, washing away the cellular waste that accumulates during the day. During this process, the fluid that surrounds brain cells flushes out molecular garbage and transfers it into the bloodstream, where it’s then filtered by the liver and kidneys and expelled from the body. That trash includes the protein amyloid, which is thought to play a key role in Alzheimer’s disease. Everyone’s brain produces amyloid during the day, but problems can arise when the protein accumulates into sticky clumps, called plaques. The longer someone is awake, the more amyloid builds up and the less time the brain has to remove it. Scientists don’t know whether regularly getting too little sleep — typically considered six hours or less a night — is enough to trigger the accumulation of amyloid on its own. But research has found that among adults aged 65 to 85 who already have plaques in their brains, the less sleep they got, the more amyloid was present and the worse their cognition. “Is lack of sleep sufficient to cause dementia? Probably not by itself alone,” said Dr. Sudha Seshadri, the founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at the University of Texas Health Science Center at San Antonio. “But it seems to definitely be a risk factor for increasing the risk of dementia, and perhaps also the speed of decline.” © 2024 The New York Times Company
Keyword: Sleep; Alzheimers
Link ID: 29400 - Posted: 07.23.2024
By Brandon Keim 1 How We Think About Animals Has a Long, Complicated History Back when I first started writing about scientific research on animal minds, I had internalized a straightforward historical narrative: The western intellectual tradition held animals to be unintelligent, but thanks to recent advances in the science, we were learning otherwise. The actual history is so much more complicated. The denial of animal intelligence does have deep roots, of course. You can trace a direct line from Aristotle, who considered animals capable of feeling only pain and hunger, to medieval Christian theologians fixated on their supposed lack of rationality, to Enlightenment intellectuals who likened the cries of beaten dogs to the squeaking of springs. But along the way, a great many thinkers, from early Greek philosopher Plutarch on through to Voltaire, pushed back. They saw animals as intelligent and therefore deserving of ethical regard, too. Those have always been the stakes of this debate: If animals are mindless then we owe them nothing. Through that lens it’s no surprise that societies founded on exploitation—of other human beings, of animals, of the whole natural world—would yield knowledge systems that formally regarded animals as dumb. The Plutarchs and Voltaires of the world were cast to the side. The scientific pendulum did swing briefly in the other direction, thanks in no small part to the popularity of Charles Darwin. He saw humans as related to other animals not only in body but in mind, and recognized rich forms of consciousness even in earthworms. But the backlash to that way of thinking was fierce, culminating in a principle articulated in the 1890s and later enshrined as Morgan’s Canon: An animal’s behavior should not be interpreted as evidence of a higher psychological faculty until all other explanations could be ruled out. Stupidity by default. © 2024 NautilusNext Inc.,
Keyword: Evolution; Attention
Link ID: 29399 - Posted: 07.23.2024
By Andrew Jacobs July 17, 2024 If you had to come up with a groovy visualization of the human brain on psychedelic drugs, it might look something like this. The image, as it happens, comes from dozens of brain scans produced by researchers at Washington University School of Medicine in St. Louis who gave psilocybin, the compound in “magic mushrooms,” to participants in a study before sending them into a functional M.R.I. scanner. The kaleidoscopic whirl of colors they recorded is essentially a heat map of brain changes, with the red, orange and yellow hues reflecting a significant departure from normal activity patterns. The blues and greens reflect normal brain activity that occurs in the so-called functional networks, the neural communication pathways that connect different regions of the brain. The scans, published Wednesday in the journal Nature, offer a rare glimpse into the wild neural storm associated with mind-altering drugs. Researchers say they could provide a potential road map for understanding how psychedelic compounds like psilocybin, LSD and MDMA can lead to lasting relief from depression, anxiety and other mental health disorders. “Psilocybin, in contrast to any other drug we’ve tested, has this massive effect on the whole brain that was pretty unexpected,” said Dr. Nico Dosenbach, a professor of neurology at Washington University and a senior author of the study. “It was quite shocking when we saw the effect size.” The study included seven healthy adults who were given either a single dose of psilocybin or a placebo in the form of methylphenidate, the generic version of the amphetamine Ritalin. Each participant underwent a total of 18 brain scans, taken before, during and after the initial dosing. © 2024 The New York Times Company
Keyword: Drug Abuse; Depression
Link ID: 29398 - Posted: 07.18.2024
By Jack Goulder Late last summer, in the waiting room of a children’s mental health clinic, I found Daniel, a softly spoken 16-year-old boy, flanked by his parents. He had been referred to the clinic for an assessment for attention deficit hyperactivity disorder (ADHD). As we took our seats on the plastic sofas in the consulting room, I asked him to tell me about the difficulties he was having. Tentatively, his gaze not leaving the floor, he started talking about school, about how he was finding it impossible to focus and would daydream for hours at a time. His exam results were beginning to show it too, his parents explained, and ADHD seemed to run in the family. They wanted to know more about any medication that could help. I had just begun a six-month placement working as a junior doctor in the clinic’s ADHD team. Doctors often take a temporary post before they formally apply to train in a speciality. Since medical school I had always imagined I would become a psychiatrist, but I wanted to be sure I was making the right choice. Armed with a textbook and the memory of some distant lectures, I began my assessment, running through the questions listed in the diagnostic manual. Are you easily distracted? Do you often lose things? Do people say you talk excessively? He answered yes to many of them. Are you accident-prone? He and his parents exchanged a knowing laugh. With Daniel exhibiting so many of the symptoms, I told them, this sounded like ADHD. I felt a sense of relief fill the room. Later that afternoon, I took Daniel’s case to a meeting where the day’s new referrals were discussed. Half a dozen senior doctors, nurses, psychologists and psychotherapists sat around the table and listened as each case was presented, trying to piece together the story being told and decide what to do next. When it was my turn, I launched into my findings, laying out what Daniel had told me and what I had gleaned from his parents about his childhood. © 2024 Guardian News & Media Limited
By Elissa Welle One question long plagued memory researcher André Fenton: How can memories last for years when a protein essential to maintaining them, called memory protein kinase Mzeta (PKMzeta), lasts for just days? The answer, Fenton now says, may lie in PKMzeta’s interaction with another protein, called postsynaptic kidney and brain expressed adaptor protein (KIBRA). Complexes of the two molecules maintain memories in mice for at least one month, according to a new study co-led by Fenton, professor of neural science at New York University. The bond between the two proteins “protects each of them,” Fenton says, from normal degradation in the cell. KIBRA preferentially gloms onto potentiated synapses, the study shows. And it may help PKMzeta stick there, too, where the kinase acts as a “molecular switch” to help memories persist, Fenton says. “As Theseus’ Ship was sustained for generations by continually replacing worn planks with new timbers, long-term memory can be maintained by continual exchange of potentiating molecules at activated synapses,” Fenton and his colleagues write in their paper, which was published last month in Science Advances. Before this study, the PKMzeta mystery had two “missing puzzle pieces,” says Justin O’Hare, assistant professor of pharmacology at the University of Colorado Denver, who was not involved in the study. One was how PKMzeta identifies potentiated synapses, part of the cellular mechanism underlying memory formation. The second was how memories persist despite the short lifetime of each PKMzeta molecule. This study “essentially proposes KIBRA as a solution to both of those—and the experiments themselves are pretty convincing and thorough. They do everything multiple ways.” PKMzeta has been widely studied, but its role in memory has been shrouded in controversy for more than a decade, Fenton says. Although early work suggested that PKMzeta is necessary for memory formation, later studies found that they still form in mice missing the gene for PKMzeta. © 2024 Simons Foundation
Keyword: Learning & Memory
Link ID: 29396 - Posted: 07.18.2024
By Ellen Barry In recent decades, mental health providers began screening for “adverse childhood experiences” — generally defined as abuse, neglect, violence, family dissolution and poverty — as risk factors for later disorders. But what if other things are just as damaging? Researchers who conducted a large study of adults in Denmark, published on Wednesday in the journal JAMA Psychiatry, found something they had not expected: Adults who moved frequently in childhood have significantly more risk of suffering from depression than their counterparts who stayed put in a community. In fact, the risk of moving frequently in childhood was significantly greater than the risk of living in a poor neighborhood, said Clive Sabel, a professor at the University of Plymouth and the paper’s lead author. “Even if you came from the most income-deprived communities, not moving — being a ‘stayer’ — was protective for your health,” said Dr. Sabel, a geographer who studies the effect of environment on disease. “I’ll flip it around by saying, even if you come from a rich neighborhood, but you moved more than once, that your chances of depression were higher than if you hadn’t moved and come from the poorest quantile neighborhoods,” he added. The study, a collaboration by Aarhus University, the University of Manchester and the University of Plymouth, included all Danes born between 1982 and 2003, more than a million people. Of those, 35,098, or around 2.3 percent, received diagnoses of depression from a psychiatric hospital. Are you concerned for your teen? If you worry that your teen might be experiencing depression or suicidal thoughts, there are a few things you can do to help. Dr. Christine Moutier, the chief medical officer of the American Foundation for Suicide © 2024 The New York Times Company
Keyword: Depression; Stress
Link ID: 29395 - Posted: 07.18.2024
By Freda Kreier Dogs’ ability to feel your pain could be innate. It is the result of centuries of co-evolution with humans, suggests a community-science study that compared the responses of dogs and pet pigs to the sound of humans crying and humming. The results were published on 2 July in Animal Behaviour1. Humans pay attention to how the animals in their lives are feeling, and it seems that this attentiveness is reciprocal. Researchers have found that horses will stop and listen longer to human growls than to laughter2. Pigs respond more strongly to sounds made by people than wild boars do3. But studies testing whether the animals are just reacting to weird human sounds, or are capable of true emotional contagion — the ability to interpret and reflect people’s emotional states — are thin on the ground. Most animals can accurately echo the feelings of only other members of their species. But studies have shown that dogs (Canis familiaris) can mirror the emotions of the people around them4,5. One question is whether this emotional contagion is rooted in ‘universal vocal signals of emotion ’ that can be understood by all domesticated animals, or is specific to companion animals such as dogs. To test this, researchers compared the stress response of dogs and pet pigs (Sus scrofa domesticus) to human sounds. Pet sounds Like dogs, pet pigs are social animals that are from a young age raised around people. But unlike dogs, pigs have been kept as livestock for most of their history with humans. So, if emotional contagion can be learnt through just proximity to people, pet pigs should respond in similar ways to dogs. The team recruited dog or pig owners around the world to film themselves in a room with their pets while playing recorded sounds of crying or humming. Researchers then tallied the number of stress behaviours — such as whining and yawning for dogs, and rapid ear flicks for pigs — exhibited during the experiment. © 2024 Springer Nature Limited
Keyword: Emotions; Evolution
Link ID: 29394 - Posted: 07.18.2024